Functional Monitoring for Motor Pathway in Brain Tumor Surgery Within Eloquent Area
Study Details
Study Description
Brief Summary
Resection of brain tumors in eloquent areas involves the risk of postoperative motor deficits. For brain tumors within or adjacent to the eloquent area, maximizing tumor resection while preserving motor function is crucially important.we used DTI-based tractography to visualize the spatial relationship between brain lesions and the nearby pyramidal tract(PT) in patients with malignant brain tumors and confirmed functional connections of the illustrated PT by direct electrical stimulation. We evaluated the reliability of DTI-based tractography for PT mapping using intraoperative subcortical stimulation ) and the usefulness of the combination of two techniques.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Detailed Description
Adverse effects caused by electrical stimulation during the operation were recorded. All subjects adopted early postoperative MRI examinations (within 3 days) to evaluate both the extent of tumor resection and the integrity of the PTs. Muscle strength was assessed preoperatively and postoperatively.The Karnofsky Performance Scale (KPS) was adopted for grading functional status at the 6-month evaluation. Further tumor progression interval and survival analysis was conducted for each subject with high-grade glioma (HGG)
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Other: intraoperative functional monitoring intraoperative functional monitoring |
Procedure: diffusion tensor tractography neuronavigation and intraoperative subcortical stimulation
All of the patients underwent tumor resection assisted with combined use of Diffusion tensor tractography-integrated functional neuronavigation and intraoperative subcortical stimulation
|
Outcome Measures
Primary Outcome Measures
- Extent of Tumor Resection [within 3 days]
Volumetric analysis was performed both before and after surgery by calculating the tumor volume on the images of enhanced 3-D MP-RAGE sequence for high-grade gliomas and FLAIR sequence for low-grade gliomas. The extent of tumor resection was the ratio of pre-op tumor volume over post-op tumor volume. Gross total resection refers to a 100% resection of the tumor volume; near-total resection refers to 95% to 100% resection; subtotal resection refers to 90% to 95% resection; partial resection refers to 75% to 90% resection; and biopsy refers to ,75% resection of the tumor volume for histological diagnosis.
Secondary Outcome Measures
- Postoperative Motor Function and Long-time Functional Status [3 days to 6 months after surgery]
Motor function was assessed early postoperatively (within 72 hours after the operation), and 1 month after discharge. The muscle strength of each subject was graded for both the upper and lower extremities with the Medical Research Council Scale. Grade 5: Muscle contracts against full resistance; Grade 4: Strength reduced, but contraction can still move joint against resistance; Grade 3: Strength further reduced such that joint can be moved only against gravity with examiner's resistance completely removed. Grade 2: Muscle can onlly move if resistance of gravity is removed. Grade 1: Only a trace or flicker of movement is seen or felt, or fasciculations are observed; Grade 0:No movement.
Other Outcome Measures
- The Specificity, Sentitivity of DTI Tractography and Accordance Rate of DTI With DsCS Results [During the operation]
The sensitivity of DTI tractography for PT mapping was calculated as the ratio between the number of subjects with positive DsCS results in the positive DTI zone (true positive) and the total number of subjects with positive DsCS results (true positive plus false negative). The specificity was measured as the ratio between the number of subjects with negative DsCS results in the negative DTI zone (true negative) and the total number of subjects with negative DsCS results (true negative plus false positive). The accordance rate of DsCS and DTI was measured as the ratio between the number of subjects with either a true-positive or true-negative DsCS result and the total number of subjects.
Eligibility Criteria
Criteria
Inclusion Criteria:
-
patients with an initial imaging diagnosis of single, unilateral, supratentorial primary glioma (or intrinsic neoplasm).
-
The lesions were involved in PTs, comprising cortical regions in the motor or somatosensory areas, cortical regions adjacent to the central gyrus, subcortical regions with an infiltrative progression along the PTs, and temporal or insular regions in relation to the internal capsule.
-
MRI enabled preoperative identification of patients in whom maximal tumor resection was likely to be achieved, and close PT approach within resection cavity at the time of surgery was possible.
Exclusion Criteria:
- patients with secondary or recurrent gliomas (or intrinsic neoplasm), patients with contraindications for MRI or direct electrical stimulation, and patients in whom initial muscle strength grades of the affected extremities was 2/5 or lower.
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | Hushan Hospital, Fudan University | Shanghai | Shanghai | China | 200000 |
Sponsors and Collaborators
- Huashan Hospital
- Shanghai Municipal Science and Technology Commission
Investigators
- Study Chair: Liangfu Zhou, Doctorate, Huashan Hospital
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- 07QA14008
- 07QA14008
Study Results
Participant Flow
Recruitment Details | |
---|---|
Pre-assignment Detail |
Arm/Group Title | Intraoperative Functional Monitoring |
---|---|
Arm/Group Description | intraoperative functional monitoring and diffusion tensor tractography All of the patients underwent tumor resection assisted with combined use of Diffusion tensor tractography-integrated functional neuronavigation and intraoperative subcortical stimulation |
Period Title: Overall Study | |
STARTED | 58 |
COMPLETED | 58 |
NOT COMPLETED | 0 |
Baseline Characteristics
Arm/Group Title | Intraoperative Functional Monitoring |
---|---|
Arm/Group Description | intraoperative functional monitoring diffusion tensor tractography neuronavigation and intraoperative subcortical stimulation: All of the patients underwent tumor resection assisted with combined use of Diffusion tensor tractography-integrated functional neuronavigation and intraoperative subcortical stimulation |
Overall Participants | 58 |
Age (years) [Mean (Full Range) ] | |
Patients enrolled |
44
|
Sex: Female, Male (Count of Participants) | |
Female |
21
36.2%
|
Male |
37
63.8%
|
Study Specific Measure [Tumor Location] (participants) [Number] | |
Frontal lobe |
22
37.9%
|
Parietal lobe |
13
22.4%
|
Insular lobe |
12
20.7%
|
Temporal lobe |
11
19%
|
Outcome Measures
Title | Extent of Tumor Resection |
---|---|
Description | Volumetric analysis was performed both before and after surgery by calculating the tumor volume on the images of enhanced 3-D MP-RAGE sequence for high-grade gliomas and FLAIR sequence for low-grade gliomas. The extent of tumor resection was the ratio of pre-op tumor volume over post-op tumor volume. Gross total resection refers to a 100% resection of the tumor volume; near-total resection refers to 95% to 100% resection; subtotal resection refers to 90% to 95% resection; partial resection refers to 75% to 90% resection; and biopsy refers to ,75% resection of the tumor volume for histological diagnosis. |
Time Frame | within 3 days |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Intraoperative Functional Monitoring |
---|---|
Arm/Group Description | intraoperative functional monitoring diffusion tensor tractography neuronavigation and intraoperative subcortical stimulation: All of the patients underwent tumor resection assisted with combined use of Diffusion tensor tractography-integrated functional neuronavigation and intraoperative subcortical stimulation |
Measure Participants | 58 |
gross total resection |
40
69%
|
near-total resection |
7
12.1%
|
subtotal resection |
7
12.1%
|
partial resection |
4
6.9%
|
Title | Postoperative Motor Function and Long-time Functional Status |
---|---|
Description | Motor function was assessed early postoperatively (within 72 hours after the operation), and 1 month after discharge. The muscle strength of each subject was graded for both the upper and lower extremities with the Medical Research Council Scale. Grade 5: Muscle contracts against full resistance; Grade 4: Strength reduced, but contraction can still move joint against resistance; Grade 3: Strength further reduced such that joint can be moved only against gravity with examiner's resistance completely removed. Grade 2: Muscle can onlly move if resistance of gravity is removed. Grade 1: Only a trace or flicker of movement is seen or felt, or fasciculations are observed; Grade 0:No movement. |
Time Frame | 3 days to 6 months after surgery |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Intraoperative Functional Monitoring |
---|---|
Arm/Group Description | intraoperative functional monitoring diffusion tensor tractography neuronavigation and intraoperative subcortical stimulation: All of the patients underwent tumor resection assisted with combined use of Diffusion tensor tractography-integrated functional neuronavigation and intraoperative subcortical stimulation |
Measure Participants | 58 |
Normal |
41
70.7%
|
Short-term motor deficit |
11
19%
|
Long-term motor deficit |
6
10.3%
|
Title | The Specificity, Sentitivity of DTI Tractography and Accordance Rate of DTI With DsCS Results |
---|---|
Description | The sensitivity of DTI tractography for PT mapping was calculated as the ratio between the number of subjects with positive DsCS results in the positive DTI zone (true positive) and the total number of subjects with positive DsCS results (true positive plus false negative). The specificity was measured as the ratio between the number of subjects with negative DsCS results in the negative DTI zone (true negative) and the total number of subjects with negative DsCS results (true negative plus false positive). The accordance rate of DsCS and DTI was measured as the ratio between the number of subjects with either a true-positive or true-negative DsCS result and the total number of subjects. |
Time Frame | During the operation |
Outcome Measure Data
Analysis Population Description |
---|
[Not Specified] |
Arm/Group Title | Intraoperative Functional Monitoring |
---|---|
Arm/Group Description | intraoperative functional monitoring and diffusion tensor tractography All of the patients underwent tumor resection assisted with combined use of Diffusion tensor tractography-integrated functional neuronavigation and intraoperative subcortical stimulation |
Measure Participants | 58 |
Sentitivity |
92.6
|
Specificity |
93.2
|
Accordance rate |
92.9
|
Adverse Events
Time Frame | Within1 week | |
---|---|---|
Adverse Event Reporting Description | We recorded the peri-operative adverse events which might influence the postoperative motor function of each subject, including cavity bleeding, death. | |
Arm/Group Title | Intraoperative Functional Monitoring | |
Arm/Group Description | intraoperative functional monitoring diffusion tensor tractography neuronavigation and intraoperative subcortical stimulation: All of the patients underwent tumor resection assisted with combined use of Diffusion tensor tractography-integrated functional neuronavigation and intraoperative subcortical stimulation | |
All Cause Mortality |
||
Intraoperative Functional Monitoring | ||
Affected / at Risk (%) | # Events | |
Total | / (NaN) | |
Serious Adverse Events |
||
Intraoperative Functional Monitoring | ||
Affected / at Risk (%) | # Events | |
Total | 0/58 (0%) | |
Other (Not Including Serious) Adverse Events |
||
Intraoperative Functional Monitoring | ||
Affected / at Risk (%) | # Events | |
Total | 0/58 (0%) |
Limitations/Caveats
More Information
Certain Agreements
Principal Investigators are NOT employed by the organization sponsoring the study.
There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed.
Results Point of Contact
Name/Title | Dr Jinsong Wu |
---|---|
Organization | Huashan Hospital |
Phone | 862152888771 |
wjsongc@126.com |
- 07QA14008
- 07QA14008